During the past decade, Emerald Coast Center for Neurological Disorders conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emerald Coast Center for Neurological Disorders" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Ipsen" with 3 trials sponsored, "Allergan" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Suven Life Sciences Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Emerald Coast Center for Neurological Disorders" are "Alzheimer Disease" (3 trials), "Cervical Dystonia" (3 trials), "Alzheimer's Disease" (2 trials), "Migraine" (1 trials) and "Migraine Headache" (1 trials). Many other conditions were trialed in "Emerald Coast Center for Neurological Disorders" in a lesser frequency.

Most popular intervention types in "Emerald Coast Center for Neurological Disorders" are "Drug" (9 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Botulinum toxin type A" (2 trials), "Azeliragon" (1 trials), "Donanemab" (1 trials) and "Donepezil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emerald Coast Center for Neurological Disorders" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Emerald Coast Center for Neurological Disorders". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Emerald Coast Center for Neurological Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Emerald Coast Center for Neurological Disorders, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".